The stock of Avanos Medical Inc (AVNS) has seen a 4.74% increase in the past week, with a -10.31% drop in the past month, and a -30.54% decrease in the past quarter. The volatility ratio for the week is 3.90%, and the volatility levels for the past 30 days are at 3.48% for AVNS. The simple moving average for the past 20 days is 0.48% for AVNS’s stock, with a -22.15% simple moving average for the past 200 days.
Is It Worth Investing in Avanos Medical Inc (NYSE: AVNS) Right Now?
The price-to-earnings ratio for Avanos Medical Inc (NYSE: AVNS) is above average at 47.20x. The 36-month beta value for AVNS is also noteworthy at 0.97. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for AVNS is 44.82M, and at present, short sellers hold a 1.52% of that float. The average trading volume of AVNS on January 20, 2025 was 381.26K shares.
AVNS) stock’s latest price update
The stock price of Avanos Medical Inc (NYSE: AVNS) has dropped by -0.81 compared to previous close of 16.05. Despite this, the company has seen a gain of 4.74% in its stock price over the last five trading days. prnewswire.com reported 2025-01-06 that ALPHARETTA, Ga., Jan. 6, 2025 /PRNewswire/ — Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will present at the 43rd Annual J.P.
Analysts’ Opinion of AVNS
CL King, on the other hand, stated in their research note that they expect to see AVNS reach a price target of $31. The rating they have provided for AVNS stocks is “Buy” according to the report published on May 22nd, 2023.
Stephens gave a rating of “Equal-Weight” to AVNS, setting the target price at $45 in the report published on August 04th of the previous year.
AVNS Trading at -10.14% from the 50-Day Moving Average
After a stumble in the market that brought AVNS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -37.22% of loss for the given period.
Volatility was left at 3.48%, however, over the last 30 days, the volatility rate increased by 3.90%, as shares sank -6.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -17.13% lower at present.
During the last 5 trading sessions, AVNS rose by +4.74%, which changed the moving average for the period of 200-days by -17.90% in comparison to the 20-day moving average, which settled at $15.84. In addition, Avanos Medical Inc saw 0.00% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AVNS starting from Greiner Michael, who sale 8,000 shares at the price of $19.12 back on Mar 14 ’24. After this action, Greiner Michael now owns 151,495 shares of Avanos Medical Inc, valued at $152,980 using the latest closing price.
Shimer Julie Ann, the Director of Avanos Medical Inc, purchase 500 shares at $19.85 during a trade that took place back on Mar 11 ’24, which means that Shimer Julie Ann is holding 50,090 shares at $9,925 based on the most recent closing price.
Stock Fundamentals for AVNS
Current profitability levels for the company are sitting at:
- 0.08 for the present operating margin
- 0.56 for the gross margin
The net margin for Avanos Medical Inc stands at 0.02. The total capital return value is set at 0.04. Equity return is now at value 1.77, with 1.28 for asset returns.
Based on Avanos Medical Inc (AVNS), the company’s capital structure generated 0.14 points at debt to capital in total, while cash flow to debt ratio is standing at 0.27. The debt to equity ratio resting at 0.16. The interest coverage ratio of the stock is 4.54.
Currently, EBITDA for the company is 50.6 million with net debt to EBITDA at 1.17. When we switch over and look at the enterprise to sales, we see a ratio of 1.24. The receivables turnover for the company is 5.17for trailing twelve months and the total asset turnover is 0.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.22.
Conclusion
In summary, Avanos Medical Inc (AVNS) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
